Page last updated: 2024-09-04

ruboxistaurin and Complications of Diabetes Mellitus

ruboxistaurin has been researched along with Complications of Diabetes Mellitus in 8 studies

Research

Studies (8)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	6 (75.00)	29.6817
2010's	2 (25.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Danis, RP; Sheetz, MJ	1
Ebadi, SA; Golbidi, S; Laher, I	1
Boyd, A; Casselini, C; Vinik, A; Vinik, E	1
Vinik, A	1
Avignon, A; Sultan, A	1
Fraser-Bell, S; Hykin, PG; Kaines, A	1

Reviews

6 review(s) available for ruboxistaurin and Complications of Diabetes Mellitus

Article	Year
Ruboxistaurin: PKC-beta inhibition for complications of diabetes. Expert opinion on pharmacotherapy, 2009, Volume: 10, Issue:17 Topics: Diabetes Complications; Enzyme Activation; Humans; Indoles; Maleimides; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt	2009
Antioxidants in the treatment of diabetes. Current diabetes reviews, 2011, Volume: 7, Issue:2 Topics: Antioxidants; Ascorbic Acid; Carnitine; Clinical Trials as Topic; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Type 2; Female; Humans; Indoles; Male; Maleimides; Oxidative Stress; Thioctic Acid; Treatment Outcome; Ubiquinone; Vitamins	2011
The protein kinase C-beta inhibitor, ruboxistaurin, for the treatment of diabetic microvascular complications. Expert opinion on investigational drugs, 2005, Volume: 14, Issue:12 Topics: Animals; Diabetes Complications; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Indoles; Maleimides; Microcirculation; Protein Kinase C; Protein Kinase C beta	2005
PKC-B inhibition: a new therapeutic approach for diabetic complications? Diabetes & metabolism, 2006, Volume: 32, Issue:3 Topics: Diabetes Complications; Diabetic Angiopathies; Enzyme Activation; Enzyme Inhibitors; Hypoglycemic Agents; Indoles; Maleimides; Protein Kinase C; Protein Kinase C beta	2006
Ruboxistaurin: LY 333531. Drugs in R&D, 2007, Volume: 8, Issue:3 Topics: Animals; Clinical Trials as Topic; Diabetes Complications; Diabetic Nephropathies; Diabetic Retinopathy; Drugs, Investigational; Humans; Indoles; Maleimides; Protein Kinase C; Rats	2007
Update on treatments for diabetic macular edema. Current opinion in ophthalmology, 2008, Volume: 19, Issue:3 Topics: Diabetes Complications; Enzyme Inhibitors; Fluocinolone Acetonide; Glucocorticoids; Humans; Indoles; Injections; Laser Coagulation; Macular Edema; Maleimides; Protein Kinase C; Treatment Outcome; Triamcinolone Acetonide; Vitrectomy; Vitreous Body	2008

Trials

1 trial(s) available for ruboxistaurin and Complications of Diabetes Mellitus

Article	Year
Quality of life and objective measures of diabetic neuropathy in a prospective placebo-controlled trial of ruboxistaurin and topiramate. Journal of diabetes science and technology, 2011, May-01, Volume: 5, Issue:3 Topics: Adult; Aged; Anticonvulsants; Diabetes Complications; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Female; Fructose; Humans; Indoles; Male; Maleimides; Middle Aged; Placebos; Protein Kinase Inhibitors; Quality of Life; Research Design; Surveys and Questionnaires; Topiramate	2011

Article

Year

Quality of life and objective measures of diabetic neuropathy in a prospective placebo-controlled trial of ruboxistaurin and topiramate.

Journal of diabetes science and technology, 2011, May-01, Volume: 5, Issue:3

Topics: Adult; Aged; Anticonvulsants; Diabetes Complications; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Female; Fructose; Humans; Indoles; Male; Maleimides; Middle Aged; Placebos; Protein Kinase Inhibitors; Quality of Life; Research Design; Surveys and Questionnaires; Topiramate

2011

Other Studies

1 other study(ies) available for ruboxistaurin and Complications of Diabetes Mellitus

Article	Year
Molecule of the month. Ruboxistaurin mesilate hydrate. Drug news & perspectives, 2003, Volume: 16, Issue:10 Topics: Clinical Trials, Phase II as Topic; Diabetes Complications; Diabetic Nephropathies; Diabetic Neuropathies; Diabetic Retinopathy; Enzyme Inhibitors; Humans; Indoles; Maleimides	2003